Inhibitory effects of chelidonic acid on IL-6 production by blocking NF-κB and caspase-1 in HMC-1 cells.
Hyun-Ji Shin, Hye-Lin Kim, Su-Jin Kim, Won-Seok Chung, Sung-Soo Kim, Jae-Young Um
Index: Immunopharmacol. Immunotoxicol. 33(4) , 614-9, (2011)
Full Text: HTML
Abstract
Chelidonic acid (CA) is a γ-pyrone which is contained in the rhizome of Chelidonium majus L. It has multiple pharmacological effects including those of a mild analgesic, an antimicrobial, an oncostatic and a central nervous system sedative, but the anti-inflammatory effect of CA and its molecular mechanisms are poorly understood. In this study, we investigated the regulatory mechanism of CA in mast cell-mediated inflammatory response by phorbol 12-myristate 13-acetate and calcium ionophore A23187. The results indicate that CA inhibits the production of interleukin-6 (IL-6) and the expression of IL-6 mRNA through the regulation of nuclear factor-κB. In addition, CA suppresses the activation and expression of caspase-1. These results provide new insights into the pharmacological actions of CA as a potential molecule for use in therapy in mast cell-mediated inflammatory diseases.
Related Compounds
Related Articles:
1985-12-01
[Biochem. Pharmacol. 34 , 4145-4150, (1985)]
1992-03-01
[Plant Physiol. 98(3) , 813-821., (1992)]
2001-05-01
[Phytochemistry 57(1) , 33-42, (2001)]
2011-01-01
[Int. Immunopharmacol. 11(1) , 39-45, (2011)]
2012-01-01
[Biol. Pharm. Bull. 35(5) , 666-71, (2012)]